iSpecimen Inc. (ISPC)

USD 3.95

(18.98%)

Operating Expenses Summary of iSpecimen Inc.

  • iSpecimen Inc.'s latest annual operating expenses in 2023 was 16.27 Million USD , down -10.23% from previous year.
  • iSpecimen Inc.'s latest quarterly operating expenses in 2024 Q2 was 3.01 Million USD , down -18.4% from previous quarter.
  • iSpecimen Inc. reported a annual operating expenses of 15.83 Million USD in annual operating expenses 2022, up 34.03% from previous year.
  • iSpecimen Inc. reported a annual operating expenses of 11.81 Million USD in annual operating expenses 2021, up 68.62% from previous year.
  • iSpecimen Inc. reported a quarterly operating expenses of 3.69 Million USD for 2024 Q1, up 6.1% from previous quarter.
  • iSpecimen Inc. reported a quarterly operating expenses of 3.48 Million USD for 2023 Q4, down -2.73% from previous quarter.

Annual Operating Expenses Chart of iSpecimen Inc. (2023 - 2018)

Historical Annual Operating Expenses of iSpecimen Inc. (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 16.27 Million USD -10.23%
2022 15.83 Million USD 34.03%
2021 11.81 Million USD 68.62%
2020 7 Million USD 15.77%
2019 6.05 Million USD 12.28%
2018 5.38 Million USD 0.0%

Peer Operating Expenses Comparison of iSpecimen Inc.

Name Operating Expenses Operating Expenses Difference
Bionano Genomics, Inc. 148.99 Million USD 89.075%
Prenetics Global Limited 60.73 Million USD 73.2%
Star Equity Holdings, Inc. 16.27 Million USD -0.032%
CareDx, Inc 277.76 Million USD 94.14%
Exact Sciences Corporation 2.06 Billion USD 99.21%
Exagen Inc. 52.29 Million USD 68.873%
Inotiv, Inc. 246.9 Million USD 93.407%
Guardant Health, Inc. 901.62 Million USD 98.195%
Biodesix, Inc. 77.41 Million USD 78.975%
BioNexus Gene Lab Corp. 3.92 Million USD -314.91%
Precipio, Inc. 13.63 Million USD -19.352%
Natera, Inc. 938.98 Million USD 98.267%
Aspira Women's Health Inc. 24.11 Million USD 32.499%
Standard BioTools Inc. 113.48 Million USD 85.657%
23andMe Holding Co. 420.73 Million USD 96.131%
Castle Biosciences, Inc. 242.78 Million USD 93.296%
Personalis, Inc. 128.14 Million USD 87.298%
Aclaris Therapeutics, Inc. 110.52 Million USD 85.273%
Applied DNA Sciences, Inc. 16.48 Million USD 1.27%
OpGen, Inc. 30.65 Million USD 46.907%
T2 Biosystems, Inc. 41.49 Million USD 60.772%
Myriad Genetics, Inc. 600.1 Million USD 97.288%
ICON Public Limited Company 755.64 Million USD 97.846%
NeoGenomics, Inc. 341.25 Million USD 95.23%
Star Equity Holdings, Inc. 16.27 Million USD -0.032%
IDEXX Laboratories, Inc. 1.09 Billion USD 98.511%
RadNet, Inc. 268.87 Million USD 93.946%
MDxHealth SA 71.25 Million USD 77.157%
Psychemedics Corporation 11.33 Million USD -43.614%
Illumina, Inc. 3.81 Billion USD 99.573%
Check-Cap Ltd. 19.28 Million USD 15.605%
Twist Bioscience Corporation 354.18 Million USD 95.404%
DarioHealth Corp. 62.17 Million USD 73.819%
Fulgent Genetics, Inc. 171.9 Million USD 90.531%
Sera Prognostics, Inc. 39.91 Million USD 59.222%
ENDRA Life Sciences Inc. 10.52 Million USD -54.716%
OPKO Health, Inc. 574.68 Million USD 97.168%
Medpace Holdings, Inc. 187.68 Million USD 91.327%
Neogen Corporation 405.23 Million USD 95.983%
Intelligent Bio Solutions Inc. 11.7 Million USD -39.017%
Prenetics Global Limited 60.73 Million USD 73.2%
Mainz Biomed B.V. 27.15 Million USD 40.056%
bioAffinity Technologies, Inc. 8.76 Million USD -85.711%
Trinity Biotech plc 46.49 Million USD 64.991%
Neuronetics, Inc. 82.25 Million USD 80.212%
Sotera Health Company 300.46 Million USD 94.583%
bioAffinity Technologies, Inc. 8.76 Million USD -85.711%